A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma.

Transl Lung Cancer Res · 2021 · PMC8044489 · PMID 33889524

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

showed a trendP=0.066so close (0.05 < p ≤ 0.1)

Patients with high stromal scores showed a trend of better overall survival than lower group (log-rank test, P=0.066), and this trend seemed more obvious after 5 years of follow-up ( Figure 1D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.